Antibodies to Escherichia coli-expressed C-terminal domains of Plasmodium falciparum variant surface antigen 2-chondroitin sulfate A (VAR2CSA) inhibit binding of CSA-adherent parasites to placental tissue.

Antibodies to Escherichia coli-expressed C-terminal domains of Plasmodium falciparum variant surface antigen 2-chondroitin sulfate A (VAR2CSA) inhibit binding of CSA-adherent parasites to placental tissue.

Item

http://www.wikidata.org/entity/Q36804761

Q36804761

about

Immunogenicity of the Plasmodium falciparum PfEMP1-VarO Adhesin: Induction of Surface-Reactive and Rosette-Disrupting Antibodies to VarO Infected Erythrocytes Antigen reversal identifies targets of opsonizing IgGs against pregnancy-associated malaria Designing a VAR2CSA-based vaccine to prevent placental malaria.High-throughput screening platform identifies small molecules that prevent sequestration of Plasmodium falciparum-infected erythrocytes.Structure of the DBL3X-DBL4ε region of the VAR2CSA placental malaria vaccine candidate: insight into DBL domain interactions Comparison of the specificity of antibodies to VAR2CSA in Cameroonian multigravidae with and without placental malaria: a retrospective case-control study.

P2860

Q27301377-B8CA298D-94AE-4AA2-968C-9454B0C2A16B Q30603697-1F05617B-3716-4D1C-A395-D241BB316A10 Q34498103-79DF62F6-CB4B-4515-9908-BCEE17056DC4 Q35197372-9F37670D-F5FF-46DE-984F-ED015EDD099D Q36139430-7DB31F5E-C3B2-42A4-9222-541756314E51 Q36336978-96BE3F41-1A63-4AB5-B0F2-9419EA7268FD

P2860

Antibodies to Escherichia coli-expressed C-terminal domains of Plasmodium falciparum variant surface antigen 2-chondroitin sulfate A (VAR2CSA) inhibit binding of CSA-adherent parasites to placental tissue.

Item

http://www.wikidata.org/entity/Q36804761

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Antibodies to Escherichia coli ...... parasites to placental tissue.

@ast

Antibodies to Escherichia coli ...... parasites to placental tissue.

@en

type

Item

label

Antibodies to Escherichia coli ...... parasites to placental tissue.

@ast

Antibodies to Escherichia coli ...... parasites to placental tissue.

@en

prefLabel

Antibodies to Escherichia coli ...... parasites to placental tissue.

@ast

Antibodies to Escherichia coli ...... parasites to placental tissue.

@en

P1476

Antibodies to Escherichia coli ...... parasites to placental tissue.

@en

P2093

Andrew V Oleinikov

http://www.w3.org/2001/XMLSchema#string

Gladys J Keitany

http://www.w3.org/2001/XMLSchema#string

Joe Lograsso

http://www.w3.org/2001/XMLSchema#string

Kathryn Wiliamson

http://www.w3.org/2001/XMLSchema#string

Michal Fried

http://www.w3.org/2001/XMLSchema#string

Richa Chaturvedi

http://www.w3.org/2001/XMLSchema#string

Tracy Saveria

http://www.w3.org/2001/XMLSchema#string

P2860

Antigenic variation in malaria: in situ switching, relaxed and mutually exclusive transcription of var genes during intra-erythrocytic development in Plasmodium falciparum

Full-length extracellular region of the var2CSA variant of PfEMP1 is required for specific, high-affinity binding to CSA

Selective upregulation of a single distinctly structured var gene in chondroitin sulphate A-adhering Plasmodium falciparum involved in pregnancy-associated malaria

The pathogenic basis of malaria

Evasion of immunity to Plasmodium falciparum malaria by IgM masking of protective IgG epitopes in infected erythrocyte surface-exposed PfEMP1.

Identification of glycosaminoglycan binding regions in the Plasmodium falciparum encoded placental sequestration ligand, VAR2CSA

Multiple var2csa-type PfEMP1 genes located at different chromosomal loci occur in many Plasmodium falciparum isolates

Differential recognition of P. falciparum VAR2CSA domains by naturally acquired antibodies in pregnant women from a malaria endemic area.

Strain-transcendent immune response to recombinant Var2CSA DBL5-ε domain block P. falciparum adhesion to placenta-derived BeWo cells under flow conditions.

Antibodies to a full-length VAR2CSA immunogen are broadly strain-transcendent but do not cross-inhibit different placental-type parasite isolates

P304

1031-1039

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/IAI.00978-12

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Patrick E. Duffy

P577

2013-01-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

234134479

http://www.w3.org/2001/XMLSchema#string

P698

23319559

http://www.w3.org/2001/XMLSchema#string

P921

Plasmodium falciparum

P932

3639618

http://www.w3.org/2001/XMLSchema#string

Antibodies to Escherichia coli-expressed C-terminal domains of Plasmodium falciparum variant surface antigen 2-chondroitin sulfate A (VAR2CSA) inhibit binding of CSA-adherent parasites to placental tissue.

about

P2860

P2860

Antibodies to Escherichia coli-expressed C-terminal domains of Plasmodium falciparum variant surface antigen 2-chondroitin sulfate A (VAR2CSA) inhibit binding of CSA-adherent parasites to placental tissue.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P921

P932